A- A A+

New Challenges in Addiction Medicine: COVID-19 Infection in Patients With Alcohol 

and Substance Use Disorders-The Perfect Storm. 

SPAGNOLO PA, Montemitro C, Leggio L.

Am J Psychiatry. 2020;177:805-807. 

https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2020.20040417

A Pandemic within a Pandemic - Intimate Partner Violence during Covid-19. 

EVANS ML, Lindauer M, Farrell ME.

N Engl J Med. 2020 Sep 16. doi: 10.1056/NEJMp2024046. 

https://www.nejm.org/doi/10.1056/NEJMp2024046

WHO. The Access to COVID-19 Tools (ACT) Accelerator

The Access to COVID-19 Tools (ACT) Accelerator, is a groundbreaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines. (WHO, 2020)

https://www.who.int/initiatives/act-accelerator

Nonfatal Opioid Overdoses at an Urban Emergency Department During the COVID-19 Pandemic. 

Ochalek TA, Cumpston KL, Wills BK, Gal TS, Moeller FG. 

JAMA. Published online September 18, 2020. doi:10.1001/jama.2020.17477

https://jamanetwork.com/journals/jama/fullarticle/2770986

Universal screening for SARS‐CoV‐2 infection: a rapid review. 

Viswanathan  M, Kahwati  L, Jahn  B, Giger  K, Dobrescu  AI, Hill  C, Klerings  I, Meixner  J, Persad  E, Teufer  B, Gartlehner  G. 

Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No.: CD013718. DOI: 10.1002/14651858.CD013718.

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013718/full/de

Cochrane Special Collections: Coronavirus (COVID-19): Maßnahmen zur Infektionskontrolle und Prävention

Erstmals veröffentlicht am 4. März 2020 und fortlaufend aktualisiert; zuletzt aktualisiert am 02. September 2020 (Änderungen werden unten aufgeführt); alle Reviews in dieser Sonderkollektion sind frei zugänglich. (Cochrane Library, 22.09.2020)

https://www.cochranelibrary.com/collections/doi/SC000040/full/de?contentLanguage=de

USA. Nora's Blog: Addressing the Unique Challenges of COVID-19 for People in Recovery 

By Dr. Nora Volkow 

September is Recovery Month, an occasion to focus on the needs of the millions of people in the U.S. living with a substance use disorder (SUD) as well as celebrate those who are trying or succeeding in putting drug use behind them. The stress and isolation of the COVID-19 pandemic are presenting enormous challenges for these individuals, but ultimately the altered realities of healthcare may create opportunities to reach more people with services and possibly even increase the reach of recovery support systems. (NIDA – National Institute on Drug Abuse, USA, 14.09.2020)

https://www.drugabuse.gov/about-nida/noras-blog/2020/09/addressing-unique-challenges-covid-19-people-in-recovery

The public health impact of Covid-19 beyond infection

In this article, Professor Maria Rosaria Galanti from Karolinska Institute provides her opinion on the adverse consequences of Covid-19. (European Society for Prevention Research - EUSPR Early Careers Forum, 23.09.2020)

https://euspr.hypotheses.org/1475

Coronakrise: Viele Obdachlose auf psychiatrischen Akutstationen

Berlin – Soziale Isolation und Armut aufgrund der wirtschaftlichen Folgen der Coronapandemie können einen Einfluss auf die psychische Gesundheit haben, verbunden mit einem Anstieg von Depression und auch der Suizidraten.

Einen Einblick in die Folgen für die psychische Gesundheit, besonders sozial schwacher Menschen während der Pandemie, gab heute Andreas Heinz, Direktor der Klinik für Psychiatrie und Psychotherapie an der Charité – Universitätsmedizin Berlin, bei einem virtuellen Podiumsgespräch der Nationalen Akademie der Wissenschaften Leopoldina. (aerzteblatt.de, 28.09.2020)

https://www.aerzteblatt.de/nachrichten/116894/Coronakrise-Viele-Obdachlose-auf-psychiatrischen-Akutstationen

Opioide und andere Substanzabhängigkeiten erhöhen Erkrankungsrisiko an COVID-19

Bethesda/Maryland – Patienten mit einer Abhängigkeit von Alkohol, Tabak, Cannabis, Opioiden oder Kokain haben ein deutlich erhöhtes Risiko, im Fall einer Infektion mit SARS-CoV-2 an COVID-19 zu erkranken. Dies geht aus einer Analyse von Patientenakten in Molecular Psychiatry (2020; DOI: 10.1038/s41380-020-00880-7) hervor. (aerzteblatt.de, 15.09.2020)

https://www.aerzteblatt.de/nachrichten/116535/Opioide-und-andere-Substanzabhaengigkeiten-erhoehen-Erkrankungsrisiko-an-COVID-19

COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. 

Wang, Q.Q., Kaelber, D.C., Xu, R. et al. 

Mol Psychiatry (2020). doi.org/10.1038/s41380-020-00880-7

https://www.nature.com/articles/s41380-020-00880-7

COVID-19 and smoking: resources, research and news

This page provides resources, research and news reports about COVID19 and smoking, vaping and other tobacco products for the information of health professionals, researchers and the general public. (Tobacco Control, Blog, UK, updated 09.09.2020)

https://blogs.bmj.com/tc/2020/03/26/covid-19-and-smoking-resources-research-and-news/

Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19. 

Blanco C, Compton WM, Volkow ND. 

JAMA Psychiatry. Published online September 01, 2020. doi:10.1001/jamapsychiatry.2020.3177

https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2769987

Global Drugs Survey. GDS COVID-19 Special Edition: Key Findings Report

The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health and relationships. Over 55,000 people took part. The survey ran for 7 weeks in (May – June 2020). (GDS, September 2020)

https://www.globaldrugsurvey.com/gds-covid-19-special-edition-key-findings-report/

COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper. 

Farhoudian A, Baldacchino A, Clark N, et al.

Basic Clin Neurosci. 2020;11(2):133-150. doi:10.32598/bcn.11.covid19.1

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368103/

Can COVID-19 related mental health issues be measured?. 

Ransing R, Ramalho R, Orsolini L, et al. 

Brain Behav Immun. 2020;88:32-34. doi:10.1016/j.bbi.2020.05.049

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248629/

COVID-19: The Hidden Impact on Mental Health and Drug Addiction. 

Chiappini S, Guirguis A, John A, Corkery JM, Schifano F. 

Front Psychiatry. 2020;11:767. Published 2020 Jul 29. doi:10.3389/fpsyt.2020.00767

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403495/

New Trends of Substance Abuse During COVID-19 Pandemic: An International Perspective.

Zaami S, Marinelli E, Varì MR. 

Front Psychiatry. 2020;11:700. Published 2020 Jul 16. doi:10.3389/fpsyt.2020.00700

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378810/

Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system 

McCarthy CP, Murphy S, Jones-O'Connor M, et al.

[published online ahead of print, 2020 Aug 19]. EClinicalMedicine. 2020;100504. doi:10.1016/j.eclinm.2020.100504

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434634/

SUCHT: Volume 66, Issue 4, August 2020 

Themenschwerpunkt: Corona und Sucht – Risiken, Forschungs- und Versorgungsbedarf

https://econtent.hogrefe.com/toc/suc/current

Conversations on COVID-19: Impacts on Communities of Color

The National Academies of Sciences, Engineering, and Medicine, USA, August 2020

https://www.nationalacademies.org/resource/conversations-on-covid-19-impacts-on-communities-of-color

Psychische Belastungen, Resilienz, Risiko- und protektive Faktoren während der SARS-CoV-2-Pandemie - Systematische Literaturanalyse und Studienergebnisse aus dem deutschen COSMO-Panel

Psychomorbidity, resilience, and exacerbating and protective factors during the SARS-CoV-2-pandemic—a systematic literature review and results from the German COSMO-PANEL. 

Gilan D, Röthke N, Blessin M, Kunzler A, Stoffers-Winterling J, Müssig M, 
Yuen KSL, Tüscher O, Thrul J, Kreuter F, Sprengholz P, Betsch C, Stieglitz RD, Lieb K

Dtsch Arztebl Int 2020; 117: 625–32. DOI: 10.3238/arztebl.2020.0625

https://www.aerzteblatt.de/archiv/215264/Psychische-Belastungen-Resilienz-Risiko-und-protektive-Faktoren-waehrend-der-SARS-CoV-2-Pandemie

Psychisches Befinden in der Bevölkerung während der COVID-19-Pandemie

Mental Health Status in the Community During the COVID-19-Pandemic

Christine Kuehner, Katharina Schultz, Peter Gass, Andreas Meyer-Lindenberg, Harald Dreßing

Psychiatr Prax, DOI: 10.1055/a-1222-9067, 21. August 2020 (online)

https://www.thieme-connect.com/products/ejournals/html/10.1055/a-1222-9067

Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. 

Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, Emperador D, Takwoingi Y, Cunningham J, Beese S, Dretzke J, Ferrante di Ruffano L, Harris IM, Price MJ, Taylor-Phillips S, Hooft L, Leeflang MMG, Spijker R, Van den Bruel A.

Cochrane Database of Systematic Reviews 2020, Issue 8. Art. No.: CD013705. DOI: 10.1002/14651858.CD013705.

Cochrane, 26.08.2020

https://www.cochrane.org/CD013705/INFECTN_how-accurate-are-rapid-tests-performed-during-health-care-visit-point-care-diagnosing-covid-19

How mental health care should change as a consequence of the COVID-19 pandemic

Moreno, Carmen et al.

The Lancet Psychiatry, Volume 7, Issue 9, 813 - 824 

https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30307-2/fulltext

Disaster psychiatry and homelessness: creating a mental health COVID-19 response

Dotson, Samuel et al.

The Lancet Psychiatry, Volume 0, Issue 0 

https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30343-6/fulltext

Smoking, SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice. 

Grundy EJ, Suddek T, Filippidis FT, Majeed A, Coronini-Cronberg S. 

Tob Induc Dis. 2020;18:58. Published 2020 Jul 3. doi:10.18332/tid/124788

https://pubmed.ncbi.nlm.nih.gov/32641924/

Top 20 on Face Masks

Almost all organizations recommend masks for the general public. Unfortunately, earlier in the pandemic, many did exactly the opposite – due to limited data but also due to concerns about diminished mask supply for healthcare workers and out of fear that masked individuals might be tempted to ignore rules of social distancing. In addition, conflicting national guidelines have led to variable public compliance. A few physicians, in line with some COVidiots, still argue against face masks. Even in late April, for example, Frank Ulrich Montgomery, a radiologist (!) and chairperson of the “World Medical Association”, declared with superb ignorance that masks were nonsense. Sadly, he attracted less attention when he later declared that his statement was a mistake (and it was a gruesome mistake); doubts are always difficult to dispel once they are raised.

Do you need some arguments to convince your patients to wear a face mask? Here we present the Top 20 studies on their effectiveness and/or efficacy.

Christian Hoffmann & Bernd S. Kamps, The Covid Textbook, 24.08.2020

https://covidreference.com/top-10-August-24

RKI. Stellungnahme der Ständigen Impfkommission zu einer künftigen Impfung gegen COVID-19 (Stand: 17.8.2020)

Epidemiologisches Bulletin 35/2020, Erscheinungsdatum 19. August 2020 

https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2020/Ausgaben/35_20.pdf

The Implications of COVID-19 for Mental Health and Substance Use

Nirmita Panchal, Rabah Kamal,Kendal Orgera, Cynthia Cox, Rachel Garfield, Liz Hamel, Cailey Muñana, and Priya Chidambaram

KFF – Kaiser Familiy Foundation, USA, 21.08.2020

https://www.kff.org/report-section/the-implications-of-covid-19-for-mental-health-and-substance-use-issue-brief/

  1. "The post-COVID era": challenges in the treatment of substance use disorder (SUD) after the pandemic. 
  2. The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 6). 
  3. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. 
  4. Opioid Use Disorder and COVID-19: Biological Plausibility for Worsened Outcomes. 
  5. Infectious Disease Outbreak Related Stigma and Discrimination during the COVID-19 Pandemic: Drivers, Facilitators, Manifestations, and Outcomes across the World